BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 7527745)

  • 1. Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous system in the Lewis rat.
    Jung S; Toyka KV; Hartung HP
    Clin Exp Immunol; 1994 Dec; 98(3):494-502. PubMed ID: 7527745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunosuppressive agent 15-deoxyspergualin functions by inhibiting cell cycle progression and cytokine production following naive T cell activation.
    Holcombe H; Mellman I; Janeway CA; Bottomly K; Dittel BN
    J Immunol; 2002 Nov; 169(9):4982-9. PubMed ID: 12391212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of experimental allergic encephalomyelitis by 15-deoxyspergualin.
    Yamamura T; Da-Lin Y; Satoh J; Tabira T
    J Neurol Sci; 1987 Dec; 82(1-3):101-10. PubMed ID: 3502003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
    Jung S; Toyka K; Hartung HP
    Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15-Deoxyspergualin inhibits interleukin 6 production in in vitro stimulated human lymphocytes.
    Borg AJ; Kumagai-Braesch M; Möller E
    Transpl Immunol; 1996 Jun; 4(2):133-43. PubMed ID: 8843590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats.
    Rott O; Cash E; Fleischer B
    Eur J Immunol; 1993 Aug; 23(8):1745-51. PubMed ID: 8393796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats.
    Phillips SM; Bhopale MK; Constantinescu CS; Ciric B; Hilliard B; Ventura E; Lavi E; Rostami A
    J Neurol Sci; 2007 Dec; 263(1-2):59-69. PubMed ID: 17603081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide--mechanisms independent of pyrimidine depletion.
    Korn T; Magnus T; Toyka K; Jung S
    J Leukoc Biol; 2004 Nov; 76(5):950-60. PubMed ID: 15328336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LF 15-0195 inhibits the development of rat central nervous system autoimmunity by inducing long-lasting tolerance in autoreactive CD4 T cells.
    Duplan V; Dutartre P; Mars LT; Liblau RS; Druet P; Saoudi A
    J Immunol; 2003 Feb; 170(4):2179-85. PubMed ID: 12574391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effects of cyclic administration of 15-deoxyspergualin on leucocyte function in patients with Wegener's granulomatosis.
    Kälsch AI; Schmitt WH; Breedijk A; Marinaki S; Weigerding S; Nebe TC; Nemoto K; van der Woude FJ; Yard BA; Birck R
    Clin Exp Immunol; 2006 Dec; 146(3):455-62. PubMed ID: 17100765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of cyclosporins A and G on functional activation of a T-helper-lymphocyte line mediating experimental autoimmune uveoretinitis.
    Caspi RR; McAllister CG; Gery I; Nussenblatt RB
    Cell Immunol; 1988 May; 113(2):350-60. PubMed ID: 2965988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats.
    Jung S; Zielasek J; Köllner G; Donhauser T; Toyka K; Hartung HP
    J Neuroimmunol; 1996 Aug; 68(1-2):1-11. PubMed ID: 8784254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The free radical scavenger S-PBN significantly prolongs DSG-mediated graft survival in experimental xenotransplantation.
    Biglarnia AR; Emanuelsson C; Quach M; Clausen F; Larsson E; Schneider MK; Tufveson G; Lorant T
    Xenotransplantation; 2012; 19(3):166-76. PubMed ID: 22702468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo administration of 15-deoxyspergulin inhibits antigen-presenting cell stimulation of T cells and NF-kappaB activation.
    Diegel ML; Nadler SG; Kiener PA
    Int Immunopharmacol; 2002 Sep; 2(10):1451-64. PubMed ID: 12400875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of experimental autoimmune keratitis by adoptive transfer of human corneal antigen-specific T-cell line.
    Akpek EK; Liu SH; Gottsch JD
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4182-8. PubMed ID: 11095613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gangliosides suppress the proliferation of autoreactive cells in experimental allergic encephalomyelitis: ganglioside effects on IL-2 activity.
    Jackson KM; Yates AJ; Orosz CG; Whitacre CC
    Cell Immunol; 1987 Jan; 104(1):169-81. PubMed ID: 2433055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta enhances the in vivo effector function and memory phenotype of antigen-specific T helper cells in experimental autoimmune encephalomyelitis.
    Weinberg AD; Whitham R; Swain SL; Morrison WJ; Wyrick G; Hoy C; Vandenbark AA; Offner H
    J Immunol; 1992 Apr; 148(7):2109-17. PubMed ID: 1347550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation.
    Beeton C; Barbaria J; Giraud P; Devaux J; Benoliel AM; Gola M; Sabatier JM; Bernard D; Crest M; Béraud E
    J Immunol; 2001 Jan; 166(2):936-44. PubMed ID: 11145670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gangliosides inhibit phenotypic and functional properties of an encephalitogenic T-helper lymphocyte line.
    Offner H; Vandenbark AA
    Cell Immunol; 1985 Oct; 95(1):84-94. PubMed ID: 2411433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.